yahoo finance

Genocea Up 5% On FDA Nod For Cancer Therapy Application; Street Sees 353% Upside

Genocea Biosciences announced that the US Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND) application for its GEN-011 cancer immunotherapy, …

Trian Fund Management Snaps Up Stake In Comcast; Analyst Sees 34% Upside

Trian Fund Management has bought up 7.1 million in Comcast shares as the activist investor believes the cable operator’s stock is undervalued.

Intel Receives US licenses To Supply Huawei – Report

Intel Corp has been granted licences from US authorities to continue supplying certain products to Huawei Technologies, even as US-China relations are at …

HPE Completes $925M Silver Peak Deal As Street Remains Sidelined

Hewlett Packard Enterprise announced the completion of its acquisition of Silver Peak, a software-defined wide area network (SD-WAN) company, in a transaction valued …

Synchronoss Sinks 7% As CEO Out For ‘Personal Misconduct’; Analyst Sees 200% Upside

Shares in Synchronoss Technologies plunged 6.5% in Monday’s extended market session after the cloud products company disclosed that its CEO resigned over allegations …

General Electric Plans To Cease Making Coal Power Plants; Shares Drop 8%

General Electric announced plans to cease making coal-fired power plants to focus on its core renewable energy and power generation businesses. The stock …

Tesla Drums Up Workers In Effort For Record 3Q Car Deliveries – Report

Tesla CEO Elon Musk is again drumming up his employees as the end of the third quarter gets closer, urging workers to produce …

Comscore Partners With Samba TV To Expand In Europe; Needham Says Buy

Comscore said Monday that it has clinched a partnership with Samba TV to expand its cross-platform TV connected footprint across Europe. Comscore (SCOR) …

AstraZeneca-Merck’s Lynparza Gets Recommended By EU For Prostate, Ovarian Cancers

AstraZeneca announced that its Lynparza drug has been recommended for marketing authorization in the European Union (EU) for patients with metastatic prostate cancer (mCRPC) …

Nikola Sinks 23% As Founder Milton Steps Down Amid Short-Seller Fraud Debacle

Shares in Nikola are diving 23% in the pre-market session after its founder Trevor Milton stepped down as executive chairman of the board …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts